BioNTech

Pfizer And BioNTech SE To Seek Emergency Use Approval From US FDA For Covid-19 Vaccine
Pfizer And BioNTech SE To Seek Emergency Use Approval From US FDA For Covid-19 VaccineSwarajya StaffNov 20, 2020 01:12 PM
Covid-19 Vaccine Developed By Pfizer-BioNTech Offers 90 Per Cent Protection Against Coronavirus Infection
Covid-19 Vaccine Developed By Pfizer-BioNTech Offers 90 Per Cent Protection Against Coronavirus InfectionSwarajya StaffNov 9, 2020 12:47 PM
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 ParticipantsSwarajya StaffSep 13, 2020 11:47 AM
A Tale Of Three Potential Vaccines – How They Stack Up In The Race For Coronavirus Prevention
A Tale Of Three Potential Vaccines – How They Stack Up In The Race For Coronavirus PreventionKaran KambleJul 24, 2020 07:19 AM
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. GovernmentSwarajya StaffJul 22, 2020 12:25 PM
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEOIANSMay 30, 2020 07:36 AM
Load More